Toxic doses of paraoxon alter the respiratory pattern without causing respiratory failure in rats

Area of Science:

• Toxicology
• Respiratory Physiology

Background:

• Acute organophosphate poisoning is a leading cause of death, primarily due to respiratory failure.
• The precise mechanisms driving organophosphate-induced respiratory failure remain incompletely understood.

Purpose of the Study:

• To investigate the effects of paraoxon, an organophosphate, on respiratory patterns and arterial blood gases in rats.
• To determine if paraoxon induces respiratory failure at near-lethal doses.
• To evaluate the efficacy of atropine in reversing paraoxon-induced respiratory alterations.

Main Methods:

• Rats were administered subcutaneous paraoxon at 10%, 50%, and 75% of the LD(50).
• Whole body plethysmography was used to monitor respiratory patterns (frequency, tidal volume, expiratory time).
• Arterial blood gases (PaO2, PaCO2, HCO3-, pH) were analyzed to assess respiratory failure. Atropine was administered to assess its effects.

Main Results:

• Paraoxon at 50% and 75% LD(50) significantly decreased respiratory frequency and increased expiratory time, without causing apnea.
• Tidal volume increased significantly at 75% LD(50) but not at 50% LD(50).
• Paraoxon did not affect PaO2, PaCO2, or HCO3-, but caused a significant decrease in arterial pH at 50% and 75% LD(50).
• Atropine completely reversed all paraoxon-induced respiratory changes.

Conclusions:

• Paraoxon alters resting ventilation in rats at doses of 50% and 75% of the LD(50).
• These alterations in breathing pattern do not lead to respiratory failure within the study period.
• Atropine is an effective antidote for paraoxon-induced respiratory dysregulation.